CpG
dinucleotides are found in clusters and thus constitute CpG islands. In vertebrates, 60 to 90% of all CpGs are
methylated. The remaining non-methylated
CpGs include functional promoters in the
region more towards 5’ end (20). They
are found to contain highly acetylated histones, H3 and H4. There are regions of which each is greater than
200 bp with high GC content (>0.6).
Methylation of cytosines at the carbon 5’ position of CpG dinucleotides
is a characteristic feature of many eukaryotic genomes (13). The salient property of CpG Island
is that it is unmethylated in the germ line. It is suggested that CpG island
methylation has a dominant effect upon comparison with histone deacetylation in
silencing genes (13). The lactoferrin
promoter that resides immediately upstream from the estrogen response element
contains 5 CpG sites within the region from 590 to 330 bp (21). Further, it is reported that CpG island in
the estrogen receptor gene is hypermethylated in human breast cancer cells and
also in sporadic colorectal tumerogenesis. Mujumder, et al., (22) have shown
that Metallothionein 1 gene is silenced by methylation of CpG islands present
within 216 bp to +1 bp with respect to transcription start in mouse
lymphosarcoma P 1798 cells. Furthermore, the intriguing feature is that there
is an association between the promoter regions of many tumor suppressor genes
and de novo methylation of an entire CpG island (23) which is the primary cause for the genesis of
tumor.
There is a
family of highly conserved proteins namely methyl CpG binding proteins sharing
a common binding domain (MBD family) selectively docks to methylated CpG
dinucleotides. Huck and Adrain (13) indicated that the transcriptional
silencing is also mediated by methyl CpG binding protein (MeCP2) which is found
to interact with Sin3/ histone deacetylase co-repressor complex. Thus,
methylation of CpG island results in the alteration of chromatin
structure followed by the direct impediment in the binding of positive factors to the regulatory elements (15) and
ultimately rendering the sites inaccessible to the basal transcriptional
machinery i.e., prevention of interaction of transcription factors with the
promoters.